Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved

Mechanisms of cisplatin-induced muscle atrophy

(2014) Hiroyasu Sakai et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Inhibition of Cisplatin-Induced Lipid Catabolism and Weight Loss by Ghrelin in Male Mice

(2013) Jose M. Garcia et al.   ENDOCRINOLOGY

CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells

(2013) Eran Gershon et al.   Obesity

Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways

(2012) Kenneth C.H. Fearon et al.   Cell Metabolism

Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients

(2012) Yuan-Shui Sun et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats

(2012) Sulaiman Sheriff et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice

(2012) Masako Sugiyama et al.   REGULATORY PEPTIDES

Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study

(2012) José M. Garcia et al.   SUPPORTIVE CARE IN CANCER

Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers

(2012) Anne E. Utech et al.   Journal of Cachexia Sarcopenia and Muscle

C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting

(2011) Guohua Zhang et al.   EMBO JOURNAL

Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients

(2011) Yuichiro Hiura et al.   International Journal of Clinical Oncology

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

CCAAT/enhancer binding protein-δ expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro

(2010) David L. Allen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Mechanisms and functions of p38 MAPK signalling

(2010) Ana Cuadrado et al.   BIOCHEMICAL JOURNAL

Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival

(2010) Xiaolan Zhou et al.   CELL

Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice

(2010) Pradyut K. Paul et al.   JOURNAL OF CELL BIOLOGY

p38 MAPK Participates in Muscle-Specific RING Finger 1-Mediated Atrophy in Cast-Immobilized Rat Gastrocnemius Muscle

(2010) Junghwan Kim et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Muscle Wasting and Impaired Myogenesis in Tumor Bearing Mice Are Prevented by ERK Inhibition

(2010) Fabio Penna et al.   PLoS One

Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems

(2010) Alessandro Fanzani et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia

(2010) Nathan A Stephens et al.   Genome Medicine

Ethical guidelines for authorship and publishing in theJournal of Cachexia, Sarcopenia and Muscle

(2010) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt

(2009) Michael R. Morissette et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size

(2009) Anne Ulrike Trendelenburg et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting

(2009) J. M. McClung et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Resistance exercise and nutrition to counteract muscle wasting

(2009) Jonathan P. Little et al.   Applied Physiology Nutrition and Metabolism

Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers

(2009) José M. Garcia et al.   GROWTH HORMONE & IGF RESEARCH

IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II-Induced Muscle Wasting

(2009) L. Zhang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Regulation of the Intracellular Localization of Foxo3a by Stress-Activated Protein Kinase Signaling Pathways in Skeletal Muscle Cells

(2009) S. Clavel et al.   MOLECULAR AND CELLULAR BIOLOGY

Ghrelin Treatment of Chronic Kidney Disease: Improvements in Lean Body Mass and Cytokine Profile

(2007) Mark D. DeBoer et al.   ENDOCRINOLOGY